Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Cerebral Decompression Illness

Paul G. Harch, M.D.

Status and phase

Unknown

Phase 1

Conditions

Cerebral Decompression Illness, All Phases

Treatments

Drug: Hyperbaric oxygen therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02105194

LSU IRB #6627

Details and patient eligibility

About

Chart review of patients who received hyperbaric oxygen therapy for cerebral decompression illness who also underwent SPECT brain blood flow imaging to see if SPECT brain imaging tracks and is consistent with the clinical condition of the patients.

Full description

SPECT brain imaging has been shown to be the most sensitive imaging modality for cerebral decompression illness. This study is a retrospective review of the PI's experience using SPECT brain imaging in the diagnosis and treatment of all phases of cerebral decompression illness over the past two decades. The purpose of the study is to see if the functional imaging is consistent with the clinical condition and cognitive testing. Chart review of symptoms, and physical exam findings will be compared before and after treatment to SPECT brain imaging radiological readings to assess concordance.

Enrollment

45 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients in the P.I.'s practice who underwent hyperbaric oxygen therapy for cerebral decompression illness in the previous two decades who also underwent SPECT brain blood flow imaging early in the course of treatment and following completion of hyperbaric oxygen therapy.

Exclusion criteria